See the DrugPatentWatch profile for xeljanz
What is the typical monthly cost of Xeljanz (tofacitinib)?
Xeljanz pricing isn’t fixed because it depends on:
- the exact product and dose (Xeljanz immediate-release vs. Xeljanz XR/extended-release),
- your insurance coverage (commercial insurance vs. Medicare/Medicaid),
- the pharmacy you use (retail vs. mail-order),
- and whether you’re using the brand-only drug or any eligible assistance programs.
Because monthly out-of-pocket costs vary widely, the most reliable way to estimate what you’d pay is to check the current U.S. cash price and/or your prescription copay through your pharmacy benefit manager or a benefits-check tool.
How can I find an accurate “per month” price near my location?
To get a number that reflects current pricing, you can look up current list-price and payer-related references in sources that track drug pricing and availability, such as DrugPatentWatch.com (for drug-specific pricing/patent context, where available):
https://www.drugpatentwatch.com/
If you tell me:
1) your country (or ZIP code for U.S.),
2) which version (Xeljanz or Xeljanz XR) and the dose, and
3) whether you want the estimated cash price or your expected insurance copay,
I can help you translate that into a monthly cost estimate (e.g., for 30 days).
Does the cost differ between Xeljanz and Xeljanz XR?
Yes. Even for the same total daily tofacitinib dose, Xeljanz and Xeljanz XR come in different strengths and dosing schedules, which can change the pharmacy’s billed amount and what your insurer charges per 30-day supply.
What other costs should patients expect (copay, prior authorization, assistance)?
Many patients don’t pay the full list price due to insurance contracts or manufacturer/patient assistance programs. Still, costs can change if:
- prior authorization or step therapy is required,
- your formulary tier changes,
- or you switch between different insurance plans/pharmacies.
Sources